Detection and cloning of potent transforming gene(s) from chewing tobacco-related human oral carcinomas

Related Experiment Videos

D Saranath1, L T Bhoite, M G Deo

  • 1Cell and Developmental Pathology Division, Tata Memorial Centre, Parel, Bombay, India.

Insights

Transforming genes in oral cancer were investigated using NIH3T3 co-transfection and nude mouse assays. Results suggest alternative oncogenes drive oral carcinomas, independent of common myc, ras, or EGF-R mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Oral carcinoma is a significant health concern, particularly in India, often linked to chewing tobacco.
  • Common oncogenes like myc, ras, and EGF-R are frequently implicated in cancer development.
  • Understanding the genetic basis of oral cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To analyze the transforming activity of DNA from human oral carcinoma tissues.
  • To identify potential oncogenes involved in oral carcinogenesis.
  • To investigate the role of alternative transforming genes in chewing tobacco-related oral cancers.

Main Methods:

  • High molecular weight DNA from 14 primary oral tumors was analyzed using NIH3T3 co-transfection and nude mouse tumorigenicity assays.
  • Southern blot hybridization was employed to detect oncogene aberrations (myc, ras, EGF-R).
  • Genomic library construction and screening were performed on secondary tumors to identify novel transforming sequences.

Main Results:

  • Twelve of 14 patient tumors exhibited transforming potential in vitro and in vivo.
  • While some primary tumors showed mutations in myc, ras, or EGF-R, most secondary tumors lacked these specific oncogene alterations.
  • Human Alu sequences were detected in transfected cells and tumors, and a genomic library identified novel clones, suggesting the involvement of uncharacterized transforming genes.

Conclusions:

  • The study indicates that oral carcinomas, particularly those related to chewing tobacco, may be driven by potent transforming genes other than the commonly studied myc, ras, and EGF-R.
  • Alternative oncogenic pathways are likely activated in oral cancer development.
  • Further research is needed to identify and characterize these novel transforming genes.

Related Concept Videos